Latest filing published 10 Jun 2024 for Longevity Health Holdings, Inc., €4,614.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -96.0%Entry US$67.05 · Close at T+365 US$2.65
- -95.3%Entry US$78.96 · Close at T+365 US$3.74
- -96.8%Entry US$75.30 · Close at T+365 US$2.38
- -88.4%Entry US$90.30 · Close at T+365 US$10.50
- -89.3%Entry US$84.90 · Close at T+365 US$9.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rajiv Shukla: trading record in brief
Rajiv Shukla is a declared insider at 3 companies; the most frequent names are Longevity Health Holdings, Inc., DermTech, Inc. and Humacyte, Inc. The record holds 38 filings, for trades running from 23 June 2017 to 6 June 2024.
No open-market sale appears; the market trades are 27 purchases worth €4.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2024 to date brings 9 purchases and no sales.
A typical purchase (the median) is worth €4,855. Of 13 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 12 purchases show a median change of -29.9%, with the price up in 42% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 10 June 2024, reports an open-market purchase of €4,614 in Longevity Health Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rajiv Shukla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$2.50Common StockSEC:0000950170-24-071092:1Canonical exit: 28 Aug 2024 (T+90)
- 2,100 shares@ US$2.63Common StockSEC:0000950170-24-071092:2Canonical exit: 4 Sept 2024 (T+90)
- 00Common StockSEC:0000950170-24-071092:3
- 20 shares@ US$2.570.1% of flowCommon StockSEC:0000950170-24-071092:0Canonical exit: 26 Aug 2024 (T+90)
- 1,939 shares@ US$2.57Common StockSEC:0000950170-24-065344:1Canonical exit: 22 Aug 2024 (T+90)
- 00Common StockSEC:0000950170-24-065344:2
- 2,100 shares@ US$2.507.8% of flowCommon StockSEC:0000950170-24-065344:0Canonical exit: 21 Aug 2024 (T+90)
- 1,515 shares@ US$2.39Common StockSEC:0000950170-24-063592:1Canonical exit: 19 Aug 2024 (T+90)
- 4,051 shares@ US$2.41Common StockSEC:0000950170-24-063592:2Canonical exit: 20 Aug 2024 (T+90)
- 00Common StockSEC:0000950170-24-063592:3
- 00Common StockSEC:0000950170-24-063586:1
- 1,172 shares@ US$2.2193.9% of flowCommon StockSEC:0000950170-24-063592:0Canonical exit: 18 Aug 2024 (T+90)
- 8,680 shares@ US$2.8837.3% of flowCommon StockSEC:0000950170-24-063586:0Canonical exit: 3 Jul 2024 (T+90)
- 00Common StockSEC:0000950170-24-002269:1
- 14,347 shares0Common StockSEC:0000950170-24-002269:0
- 5,014 shares@ US$2.91Common StockSEC:0000950170-23-067903:1Canonical exit: 27 Feb 2024 (T+90)
- 5,600 shares@ US$2.66Common StockSEC:0000950170-23-067903:2Canonical exit: 28 Feb 2024 (T+90)
- 502 shares@ US$2.50Common StockSEC:0000950170-23-067903:3Canonical exit: 29 Feb 2024 (T+90)
- 00Common StockSEC:0000950170-23-067903:4
- 2,501 shares@ US$2.920110.8% of flowCommon StockSEC:0000950170-23-067903:0Canonical exit: 26 Feb 2024 (T+90)
- 1,185 shares@ US$2.77724.9% of flowCommon StockSEC:0000950170-23-066517:0Canonical exit: 20 Feb 2024 (T+90)
- 2,715 shares@ US$2.946211.9% of flowCommon StockSEC:0000950170-23-066517:1Canonical exit: 22 Feb 2024 (T+90)
- 2,100 shares@ US$2.97499.2% of flowCommon StockSEC:0000950170-23-066517:2Canonical exit: 25 Feb 2024 (T+90)
- 00Common StockSEC:0000950170-23-066517:3
- 3,750 shares@ US$2.62Common StockSEC:0000950170-23-065682:1Canonical exit: 18 Feb 2024 (T+90)
25 of 38 declarations
